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Abstract
Recurrent airway obstruction is one of the most common airway diseases affecting mature 
horses. Increased bronchoalveolar mucus, neutrophil accumulation in airways, and airway 
obstruction are the main features of this disease. Mucociliary clearance is a key component of 
pulmonary defense mechanisms. Cilia are the motile part of this system and a complex linear 
array of dynein motors is responsible for their motility by moving along the microtubules 
in the axonemes of cilia and flagella. We previously detected a QTL for RAO on ECA 13 in a 
half-sib family of European Warmblood horses. The gene encoding DNAH3 is located in the 
peak of the detected QTL and encodes a dynein subunit. Therefore, we analysed this gene 
as a positional and functional candidate gene for RAO. In a mutation analysis of all 62 exons 
we detected 53 new polymorphisms including 7 non-synonymous variants. We performed 
an association study using 38  polymorphisms in a cohort of 422 animals. However, after 
correction for multiple testing we did not detect a significant association of any of these 
polymorphisms with RAO (P>0.05). Therefore, it seems unlikely that variants at the DNAH3 
gene are responsible for the RAO QTL in European Warmblood horses.
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Introduction
RAO or heaves is one of the most common airway diseases affecting mature horses. RAO 
is characterised by bronchospasms and increased mucus and neutrophil accumulation in 
the airways. It occurs following exposure of susceptible horses to antigens and endotoxins 
present in hay and stable dust (Cunningham & Dunkel 2008, Léguillette 2003). Because of 
many similarities of this disease to human asthma it is used as an animal model of human 
asthma (Deaton 2006, Leclere et al. 2011).
The prevalence of RAO is estimated at 10-20 % of adult horses living in cold and temperate 
climates. There is no breed or sex predisposition for RAO (Leclere et al. 2011). RAO is a complex 
trait controlled by environmental and genetic factors. In a Warmblood population there was 
evidence for the presence of one or more major genes and the heritability in a study cohort 
exposed to hay feeding was estimated to approach 100 %. Thus hay-feeding may be the only 
significant environmental factor influencing this disease (Gerber et al. 2009).
Mucociliary clearance is a key component of pulmonary defense mechanisms. It involves 
the regulation of ion transport by the airway epithelium, mucus secretion, and ciliary 
function (Knowles & Boucher 2002). Cilia and flagella contain motile microtubules with 
a »9+2«structure, in which two central singlet microtubules are surrounded by nine outer 
doublet microtubules. A complex linear array of dynein motors is responsible for their 
motility (Brokaw 2009, Hayashi & Shingyogi 2008).
Cytoplasmic and axonemal dyneins are involved in the cytoplasmatic movement of 
organelles and the bending of cilia and flagella, respectively (Bartoloni et al. 2001). The DNAH 
proteins assemble with intermediate and light chains into large multiprotein complexes to 
form inner and outer dynein arms (Holzbaur & Vallee 1994, DiBella & King 2001). The inner 
and outer dynein arms slide on the outer doublet microtubules by hydrolysing ATP.
Defects in the motile cilia are responsible for the most prominent ciliopathy in mammals, 
called primary ciliary dyskinesia. One aspect of PCD is respiratory disease due to impaired 
mucociliary clearance. Additional features of PCD are sperm immobility and randomisation 
of left-right asymmetry (Afzelius 1976, Rossman et al. 1980). The different features of PCD are 
now clearly explained by mutations involving various subunits of the axonemal structures 
(Lee 2011).
Due to their importance for mucociliary clearance the genes encoding dynein subunits 
can be considered functional candidates for RAO. In a previous microsatellite-based linkage 
study we detected a QTL for RAO in a half-sibling family of European Warmblood horses with 
a peak of about 4 Mb extending from 24-28 Mb on ECA 13 (Swinburne et al. 2009). The DNAH3 
gene expressed in trachea, testis and brain (Maiti et al. 2000) is located on ECA 13 at 26.4-
26.6 Mb in the peak region of the detected QTL. Therefore, we analysed the equine DNAH3 
gene as a positional and functional candidate gene and performed an association study in a 
cohort of European Warmblood horses.
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Material and methods
Animals and phenotypes
For variant detection we selected two RAO-affected and two non-affected half-sibling 
offspring of a previously described European Warmblood family, in which the QTL on ECA 13 
was detected (Swinburne et al. 2009). We selected these four horses based on their 
phenotypes and marker haplotypes at the QTL.
For the association analysis we used 464 European Warmblood horses that were unrelated 
at the grandparental level. More than 60 % (281) of the sampled horses were from Switzerland 
and Germany. Additional horses were from Belgium, the Czech Republic, Denmark, France, 
Hungary, Ireland, Latvia, The Netherlands, Poland, Portugal, Russia, Slovakia, and Sweden. 
Cases and controls were matched according to countries in order to minimise the stratification. 
A multidimensional scaling plot of genome-wide SNP data from these horses did not result in 
different clusters between cases and controls (data not shown).
We determined the phenotypes in our sample population according to the »Horse Owner 
Assessed Respiratory Signs Index« (Ramseyer et al. 2007, Laumen et al. 2010). The HOARSI 
gives scores from 1-4, which correspond to absent, mild, moderate and severe clinical signs 
respectively. Briefly, horse owners were contacted by phone and only horses with clinical 
signs that had persisted for at least 2 months were included in the study. All horses were 5 
years or older, with at least a 12-month history of hay-feeding. A standardised questionnaire 
was used to gather information from the horse owners about the animals’ history of chronic, 
regular or frequent coughing, increased breathing effort at rest, increased breathing effort 
after exercise, and nasal discharge. The HOARSI classification refers to the period when the 
horses were exhibiting the most severe clinical signs. We selected horses with HOARSI 1 as 
controls and horses with HOARSI 3 or 4 as RAO cases. We used an overlapping set of horses in 
a related study (Shakhsi-Niaei et al. 2012).
Mutation analysis and genotyping
We amplified all 62 DNAH3 exons and their flanking regions in 4 horses (Table 1). The PCR 
products were directly sequenced on an ABI 3730 sequencer (LifeTechnologies, Carlsbad, 
CA, USA) and polymorphisms were identified using Sequencher software v4.9. (GeneCodes, 
Ann Arbor, MI, USA). The newly identified variants were submitted to the Single Nucleotide 
Polymorphism Database (dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/).
For the association study we determined the genotypes of 35 SNPs by using Golden 
Gate assays on a BeadXpress station (Illumina Inc., San Diego, CA, USA) followed by data 
analysis with the BeadStudio v3 software (Illumina Inc, San Diego, CA, USA). The genotypes 
of 4 additional SNPs in the region were available from equine SNP50 Beadchip data (Illumina 
Inc, San Diego, CA, USA). All genomic positions refer to the EquCab 2 assembly (http://www.
ncbi.nlm.nih.gov/projects/mapview/). The equine cDNA and protein positions refer to the 
database accessions XM_001491853.3 and XP_001491903.2, respectively.
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Table 1
Primer sequences. The positions correspond to chromsome 13 in the Equus caballus 2 genome assembly.        
 Start Stop Exon Primer Forward Sequence (5'>3') Reverse Sequence (5'>3') Tm Product, bp
1 26.419.946 26.420.804 1 DNAH3_P1 TGCATTTAGGCCTCTCCAA CCTTCACACCCACTTCCAA 59.43 859
2 26.424.250 26.425.322 2+3 DNAH3_P2+3 TGGGGATGAGAAGGGTGTT ACAGCCAGGACCAGAATCC 55.16 1 073
3 26.427.888 26.428.853 4+5 DNAH3_P4+5 TCCCCTTAGTGTGCTCCTG GCTGCCATTCTGCAACCTA 59.39 966
4 26.431.430 26.432.444 6 DNAH3_P6 TCTGGTGTCATGGGGAAAA TGACCTACTGCGTGCACAA 59.96 1 015
5 26.432.363 26.433.609 7 DNAH3_P7 AGCTCTTTGATGGTGATGGA GCAGGGCTACTCCCACAGT 59.14 1 247
6 26.436.353 26.437.412 8 DNAH3_P8 AGCCATCAGGGGTAGGTCT GGATTTCTCTGGCTTTGGA 58.17 1 060
7 26.438.081 26.438.589 9 DNAH3_P9 ATGAGCCATCTGCCTTGTC AACGACTTCTCAGCTTCTGC 58.09 509
8 26.439.899 26.440.415 10 DNAH3_P10 AGCCATACCCAGCCCTTAT AGATGCACGGCCATATTTT 58.27 517
9 26.440.671 26.441.693 11 DNAH3_P11 GCCCAAGCTCTTTCCAGT TCATGCTGACGTTTTTCCA 58.09 1 023
10 26.442.941 26.443.713 12 DNAH3_P12 GGAAGTGGGGAGAGGAAGT TGCTGCCTTTTCTTATCATGT 57.81 773
11 26.445.159 26.446.002 13+14 DNAH3_P13+14 TTCAGTGTATGTTTTGCCACA ATTGCCTCAGGATGCTTTC 57.75 844
12 26.450.454 26.451.432 15 DNAH3_P15 CCCATCAAGGATTTTCAGG GGTAGAGGGCACAGCTCAT 57.87 979
13 26.451.267 26.452.213 16 DNAH3_P16  GCTCTCCACAAGCCAAGTT CAGTGAAGCAGGCTGAAAA 57.85 947
14 26.460.129 26.460.774 17 DNAH3_P17 AATGTGACTGGGCTTTCGT GCTGACTTGCCTCAAAGGT 58.08 646
15 26.460.362 26.461.431 18 DNAH3_P18 TTGGTTCTGGTCCTTGGTT TCCCCACTTTCCATCCTTA 57.94 1 070
16 26.470.588 26.471.110 19 DNAH3_P19 GCTCAGGGAATTACAGCTACA CTGGCTGGCACAATACTCA 57.76 523
17 26.474.688 26.475.249 20 DNAH3_P20 CAAGTGCTGGTGGGAGAC CACCCAAAGTGAAGGTTCC 57.79 562
18 26.478.447 26.478.714 21 DNAH3_P21 TGTCTCCTCCCGTTGAGTT GGGACCCTTTCTCTGTGAG 57.69 268
19 26.485.549 26.485.919 22 DNAH3_P22 GGGTGGAGATCTGAGCTGT TGCCCTTACTTGGATGGTT 57.86 371
20 26.486.494 26.486.969 23 DNAH3_P23 ATCAGTGGGGCTGTGATG CCTCTAGGGAGGTGGGATT 57.93 476
21 26.487.920 26.488.405 24 DNAH3_P24 TGGCTCAGTTGGTTTCAGA GTCTCTTGGGGAATGGAGA 57.71 486
22 26.491.118 26.491.979 25 DNAH3_P25 CAACCTCTATGCCCCAGAC CGGCAGGAGTGGAAGTAAT 57.92 862
23 26.492.393 26.492.909 26 DNAH3_P26 TGTCATTTGCCTCCTGAGA GCCCCAAGATTTACAAGGA 57.70 517
24 26.494.125 26.494.769 27 DNAH3_P27 TAAGCCCAGACGTGTCAAG ATTGGAGGAGGAGGAGAGG 57.79 645
25 26.497.108 26.498.098 28 DNAH3_P28 GCTAATGCCTGGAGGTCAG GGGTGTGTGAGGAGGAAAG 58.22 991
26 26.499.486 26.499.957 29 DNAH3_P29 AGTGAGAGGTGGCCTTCTG AGTAAGAGCCCTGCTTGGA 58.01 506
27 26.501.026 26.501.613 30+31 DNAH3_P30+31 CCAGTTTCTTTCCCGTGTC CCTGTCATTGGGGAGCTG 59.16 588
28 26.501.601 26.502.619 32 DNAH3_P32 CCCCAATGACAGGGTCTTA TGTTGGGAAAGTGGTTGTG 57.67 1 019
29 26.503.380 26.504.117 33 DNAH3_P33 AGCCCTCCTTTCCTTGATT ACTCTTGGTGCGTGTGATG 57.99 738
30 26.505.289 26.506.431 34+35 DNAH3_P34+35 CAAATGATAGGGCTTCTCCA TTCCTGACTCCAGCAAACA 57.43 1 143
31 26.507.364 26.507.813 36 DNAH3_P36 TAGTTGGGTGCAGAGCAAA AGAATCCAGGGACAGCAAA 58.10 450
Archiv Tierzucht 56 (2013) 1, 1-10 5
Table 1 continued
Primer sequences. The positions correspond to chromsome 13 in the Equus caballus 2 genome assembly.     
 Start Stop Exon Primer Forward Sequence (5'>3') Reverse Sequence (5'>3') Tm Product, bp
32 26.509.133 26.509.688 37 DNAH3_P37 TGTTGGCTGGTCTTTGAGA AGCAACAAGGCTTTTAACCA 57.72 556
33 26.512.163 26.512.417 38 DNAH3_P38 TCAGACCATCTCTGTCTCCAC GAGCTGTCCCTCCTGCTTA 57.94 255
34 26.514.273 26.514.847 39 DNAH3_P39 CTGGTCCTGGAGTTGGTGT GTGAGGCAATGGAGAAAGG 58.36 575
35 26.516.444 26.516.835 40 DNAH3_P40 CCTATGGGCCGTACAATTC TCATGGGAGGAAAAACAGG 58.19 392
36 26.519.054 26.519.787 41 DNAH3_P41 GGCCTCTCACAACAAAACC CAAACGGCTTAGGGACATT 57.90 734
37 26.531.911 26.532.668 42 DNAH3_P42 CTGACAACATGGAGTTTCACC AATGGGCAGGAGTTGTAGG 57.82 758
38 26.534.404 26.535.138 43 DNAH3_P43 TGCCAAGACATAGCCTCCT ACACCACAATCCCCTTCTG 58.37 735
39 26.536.286 26.536.965 44 DNAH3_P44 TGCCAATCTGTGCATCTTT TGGAGGCTTTCTGTTCCTC 57.85 680
40 26.541.797 26.542.677 45+46+47 DNAH3_P45+46+47 GGATAACTAGGCCCAAGAGG AACGGAACCCGAAATCTG 58.13 881
41 26.543.437 26.544.439 48 DNAH3_P48 GAATGTGCTCAGGGGAAAC TGGAGAGGGTTCAGAGGAA 58.17 1 003
42 26.545.331 26.545.711 49 DNAH3_P49 CACTTCCCAGGCACTCAC TGGAATATTTGGTTGGGGTA 57.64 381
43 26.547.068 26.547.557 50 DNAH3_P50 CACCTCCCCAGTTCTTCTC GTCTCATTTGGTGCCCTCT 57.40 490
44 26.551.417 26.551.713 51 DNAH3_P51 TCATTTCTGCTCTTGCCAAT GTTCCCTCCCTTTGCTCTC 58.63 297
45 26.556.761 26.557.283 52 DNAH3_P52 CCAGTTAGAGCCACCCTTG ACATCCTGGTGCCATTCTT 58.11 523
46 26.560.227 26.561.280 53 DNAH3_P53.1 GGCTTTACGTCTCGACTGG TGCTGCTTGAATGTGGACT 58.18 1 054
47 26.559.366 26.560.614 53 DNAH3_P53.2 GCTCCTGTTGCCTTCTCC TCTGCTCGCTTCTGGTTC 58.06 1 249
48 26.560.466 26.561.379 53 DNAH3_P53.3 TCTGCCTGTGAGGGTCTGT GGGAGGTAATGTGGGTTCC 59.22 914
49 26.561.162 26.562.138 53 DNAH3_P53.4 TATGTGAGGACGCTGGAAA ATCAGGCCTTCGAGTTTTG 57.82 977
50 26.561.940 26.562.481 53 DNAH3_P53.5 AGCTGCTTTTCTCCCTCCT TCCACCCATTCTGGACTTT 58.06 542
51 26.566.835 26.567.681 54 DNAH3_P54 TCAGAGCAAAAGAGGAATCAA TCACCTCCCTCCAACAACT 57.87 847
52 26.570.239 26.570.543 55 DNAH3_P55 GGGTCTGTTGTTCCTCCAG GATCTCTCCCCCTGCAAC 58.05 305
53 26.571.932 26.572.318 56 DNAH3_P56 ATTCATGGGGCTGAAAGAG CCAGCACAGTAACCAGCAT 57.46 387
54 26.575.939 26.576.594 57 DNAH3_P57 GTAGAGCTCCTTGGCTGGA CCCCTTTTTCATCCTTCCT 58.07 656
55 26.576.497 26.577.249 58 DNAH3_P58 TTCAGAAGGTGCCAGAAGG TGGAAAACTGCATGGAAAA 58.30 753
56 26.578.965 26.579.435 59 DNAH3_P59 TTCACTGCTTGAAGTTTACCC TACGGTTAGCCTGTGCTTG 57.27 471
57 26.579.711 26.580.619 60 DNAH3_P60  ATCTGGAGCAGCAAGAACC TCCCCTAACTCTCGGAAGA 57.67 909
58 26.581.215 26.582.035 61 DNAH3_P61 CAGCTTGTACCTGGGCTTT TTGGTATGATGGTGGCAGA 58.19 821
59 26.582.915 26.583.900 62 DNAH3_P62 GCATCTGACTCTAACCCCACT ACCCAAACCTCTTTCAACCT 57.94 986
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Protein analysis
In order to analyse the evolutionary conservation of the non-synonymous variants, we 
prepared multi-species alignments of the DNAH3 protein sequences using the ClustalW2 
software (European Bioinformatics Institute, Cambridge, UK; http://www.ebi.ac.uk/Tools/
msa/clustalw2/).
Association analysis
We removed individuals and markers with less than 90 % call rate with the Plink software 
(Purcell et al. 2007). We also excluded markers with a minor allele frequency of less than 
0.05 and markers that strongly deviated from Hardy-Weinberg equilibrium (P<0.001). 
Subsequently, we performed an allelic association study using chi-square tests. We also 
performed haplotypic association analyses using sliding windows of 3 and 7 markers, 
respectively. We corrected for multiple testing by applying the Bonferroni correction.
Results and discussion
Mutation analysis of the DNAH3 gene
We sequenced 34 156 nucleotides containing all 62 exons with 12 255 nucleotides of coding 
sequence of the DNAH3 gene in two RAO affected and two control horses. These four horses 
were half-sibling offspring of the European Warmblood family, in which the QTL on ECA 13 
was originally detected. We identified a total of 53 new polymorphisms including 7 non-
synonymous variants in addition to 4 previously known SNPs in the region (Table 2). Protein 
sequence alignment showed that 4 of these 7 non-synonymous variants led to amino 
acid exchanges in highly conserved positions (p.Gln1227Arg, p.Met2357Val, p.Gln2665Arg, 
p.Ser3033Cys; Figure 1). These variants are located either in or very close to functionally 
annotated domains of the DNAH3 protein (Table 3). It has to be cautioned that the 5’-end of 
the predicted horse DNAH3 transcript (XM_001491853.3) corresponding to the first exon is 
very different from the human ortholog. Thus there may be an error in the equine genome 
assembly or the annotation of the equine DNAH3 gene. Such a hypothetical error might 
alter the positions of the identified variants by about 30 amino acids. The human-horse 
relationships are given in Table 3.
Association analysis of DNAH3 variants with RAO 
For the association study we genotyped 39 SNPs including all 13 exonic variants in a cohort of 
464 animals. We removed one marker due to low minor allele frequency and 42 horses due to 
low call rates, so that 422 horses (230 cases & 192 controls) and 38 markers remained for the 
final allelic association analysis (Table 2). All of the tested markers were in Hardy-Weinberg 
equilibrium and had similar allele distributions between cases and controls with raw P-values 
greater than 5 %. As 38 markers were tested, a Bonferroni-corrected significance threshold 
would have been 0.05 / 38=0.0013. We also did not detect a significant haplotype association.
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Table 2
Polymorphisms of the equine DNAH3 gene and association data
SNP
DNAH3 
Position
ECA 13
Position
Function
Allele
1
Frequency Allele 1
Allele
2
Chi-
square
P-value
Odds 
RatioCases 
(n = 230)
Controls 
(n =192)
c.-263C>T 5‘-UTR 26 420 431 - C 0.400 0.466 T 3.706 0.054 0.764
c.-206T>A 5‘-UTR 26 420 488 - T 0.446 0.396 A 2.169 0.141 1.230
c.135+46C>G intron 2 26 424 538 - - - - - -
c.135+238T>C intron 2 26 424 730 - C 0.469 0.486 T 0.212 0.645 0.936
c.135+336C>T intron 2 26 424 828 - - - - - -
c.135+388T>C intron 2 26 424 880 - - - - - -
c.243T>C exon 3 26 425 126 p.= T 0.074 0.091 C 0.828 0.363 0.796
c.431+11A>G intron 4 26 428 077 - G 0.465 0.479 A 0.167 0.683 0.945
c.431+169C>A intron 4 26 428 235 - - - - - -
BIEC2-226005 intron 5 26 429 354 - C 0.454 0.466 T 0.129 0.720 0.951
BIEC2-226006 intron 5 26 429 577 - T 0.454 0.466 G 0.129 0.720 0.951
c.992+3309A>T intron 7 26 436 824 - A 0.450 0.477 T 0.594 0.441 0.899
c.1033A>G exon 8 26 436 881 p.Lys345Glu G 0.352 0.397 A 1.787 0.181 0.825
c.1494+58A>G intron 10 26 440 284 - - - - - -
c.14942+936C>T intron 10 26 441 163 - T 0.448 0.474 C 0.569 0.451 0.900
c.1531G>A exon 11 26 441 265 p.Val511Ile A 0.450 0.477 G 0.603 0.438 0.898
c.1824+121C>T intron 13 26 445 527 - C 0.441 0.448 T 0.037 0.847 0.974
c.2424+558A>G intron 17 26 460 868 - G 0.091 0.096 A 0.063 0.802 0.942
c.2781+168T>C intron 19 26 471 046 - - - - - -
c.2988+12T>G intron 21 26 478 616 - T 0.067 0.073 G 0.098 0.754 0.919
c.3285+49T>C intron 23 26 486 786 - T 0.194 0.181 C 0.226 0.635 1.088
c.3624+52G>A intron 25 26 491 543 - - - - - -
c.3624+85C>T intron 25 26 491 576 - - - - - -
c.3624+124T>C intron 25 26 491 615 - - - - - -
c.3624+272G>A intron 25 26 491 763 - - - - - -
c.3624+306T>C intron 25 26 491 797 - - - - - -
c.3624+1110G>A intron 25 26 492 602 - A 0.363 0.375 G 0.127 0.721 0.950
c.3680A>G exon 26 26 492 718 p.Gln1227Arg A 0.312 0.307 G 0.024 0.877 1.023
c.4142+60T>C intron 29 26 499 841 - T 0.480 0.453 C 0.627 0.429 1.116
c.4272A>G exon 31 26 501 439 p.= A 0.435 0.430 G 0.022 0.882 1.021
c.4634+314A>G intron 33 26 503 913 - - - - - -
c.4815C>T exon 34 26 505 595 p.= C 0.117 0.079 T 3.297 0.069 1.542
c.4854+525A>T intron 34 26 506 159 - T 0.117 0.083 A 2.653 0.103 1.463
c.4989+1139T>C intron 35 26 507 511 - T 0.298 0.302 C 0.018 0.893 0.980
c.5101+1509C>T intron 36 26 509 216 - T 0.137 0.104 C 2.100 0.147 1.365
c.5160T>C exon 37 26 509 281 p.= T 0.117 0.081 C 3.020 0.082 1.506
c.5343+22A>G intron 37 26 509 486 - - - - - - - -
c.5444+1973T>C intron 38 26 514 321 - - - - - - - -
c.5444+1983T>C intron 38 26 514 331 - - - - - - - -
c.5550+17T>C intron 38 26 514 536 - T 0.132 0.115 C 0.514 0.473 1.164
c.5550+141C>T intron 38 26 514 660 - - - - - -
BIEC2-226016 intron 39 26 516 372 - T 0.309 0.308 G 0.001 0.977 1.004
BIEC2-226017 intron 39 26 516 538 - T 0.309 0.308 C 0.001 0.977 1.004
c.5644G>A exon 40 26 516 727 p.Ala1882Thr G 0.306 0.310 A 0.017 0.895 0.980
c.5926+53T>A intron 41 26 519 441 - T 0.493 0.489 A 0.014 0.906 1.017
c.5926+270T>C intron 41 26 519 658 - - - - - -
c.6030+79G>C intron 42 26 532 238 - G 0.011 0.008 C - - -
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SNP
DNAH3 
Position
ECA 13
Position
Function
Allele
1
Frequency Allele 1
Allele
2
Chi-
square
P-value
Odds 
RatioCases 
(n = 230)
Controls 
(n =192)
c.6120T>C exon 43 26 534 479 p.= T 0.298 0.310 C 0.149 0.700 0.943
c.6505+25T>G intron 44 26 536 729 - G 0.454 0.442 T 0.126 0.723 1.051
c.6786+39A>G intron 46 26 542 273 - - - - - -
c.7069A>G exon 48 26 543 688 p.Met2357Val G 0.135 0.115 A 0.729 0.393 1.197
c.7994A>G exon 51 26 551 513 p.Gln2665Arg G 0.100 0.096 A 0.031 0.859 1.042
c.8362+2699G>A intron 52 26 559 821 - G 0.093 0.083 A 0.266 0.606 1.134
c.9098C>G exon 53 26 561 025 p.Ser3033Cys G 0.092 0.079 C 0.430 0.512 1.178
c.10245G>A exon 53 26 562 172 p.= G 0.093 0.083 A 0.266 0.606 1.134
c.11247+235A>G intron 57 26 576 428 - A 0.300 0.304 G 0.017 0.898 0.981
c.11558+725T>C intron 59 26 579 915 - T 0.222 0.208 C 0.222 0.637 1.083
Table 2 continued
Polymorphisms of the equine DNAH3 gene and association data
Figure 1
Multiple species alignment of the DNAH3 protein sequence at the sites of non-synonymous variants in the 
horse. Four of the seven variants lead to amino acid exchanges in highly conserved positions.
Table 3
Protein domain assignment of non-synonymous variants
Variants
Corresponding 
human position
Domain Remark Region
p.Lys345Glu 375 Stem 1..1390
p.Gln1227Arg 1 259 Stem 1..1390
p.Ala1882Thr 1 914 --
Between the AAA 2 and AAA 3 
domains
1904..2035
p.Met2357Val 2 389 --
Between the AAA 3 and AAA 4 
domains
2285..2394
p.Gln2665Arg 2 697 Stalk 2661..2960
p.Ser3033Cys 3 065 AAA 5 3045..3275
The numbering refers to the equine protein accession XP_001491903.2.   The predicted equine protein differs at its N-terminus 
from the human protein, possibly due to an annotation error in the horse genome reference sequence. The predicted equine 
protein shows high homology to its human ortholog starting from amino acid 11 in horse and amino acid 41 in human. 
The domain positions correspond to the human DNAH3 protein from the UniProtKB/Swiss-Prot accession Q8TD57. 
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In previous association studies for RAO on ECA 13, we found the strongest association for 
the marker BIEC2-224511 (Shakhsi-Niaei et al. 2012). This marker has a raw P-value of 0.015 in 
the 422 horses of this study and thus shows an almost four-fold stronger association than the 
best-associated marker from the DNAH3 gene. BIEC2-224511 is located at position 24 309 405, 
approximately 2 Mb away from the DNAH3 gene. The best associated marker in the DNAH3 
gene (c.-263C>T) is at the left boundary of the DNAH3 gene and thus also physically closest to 
BIEC2-224511 of all tested markers (Table 2).
The lack of association of the tested DNAH3 markers indicates that variants at the DNAH3 
gene are most likely not responsible for the RAO QTL in European Warmblood horses.
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